We only have this paper's title and publication details.
Read it at the sourceReal-world analysis reveals consolidation with stem cell transplantation improves outcomes in high-risk lymphoma patients, suggesting significant clinical advantages.
ENKTCL patients with high-risk characteristics could benefit more from allo-HSCT as consolidation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: